Sam Eldessouky - 28 Feb 2024 Form 4 Insider Report for Bausch & Lomb Corp (BLCO)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
01 Mar 2024, 16:28:54 UTC
Prior SEC filing
27 Jul 2023
Next SEC filing
04 Mar 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Debra E. Levin, attorney-in-fact

Key filing fact

Sam Eldessouky filed Form 4 for Bausch & Lomb Corp (BLCO) on 01 Mar 2024.

Key facts

  • This page summarizes Sam Eldessouky's Form 4 filing for Bausch & Lomb Corp (BLCO).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 01 Mar 2024, 16:28.

Change

  • Previous filing in this sequence was filed on 27 Jul 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BLCO transaction

Common Shares, No Par Value

Award

Transaction value
$0
Shares
+50,335
Change %
+25%
Price
$0.000000
Shares after
248,634
Date
28 Feb 2024
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BLCO transaction Derivative

Non-Qualified Stock Options (right to purchase)

Award

Transaction value
$0
Shares
+152,439
Change %
Price
$0.000000
Shares after
152,439
Date
28 Feb 2024
Ownership
Direct
Underlying class
Common Shares, No Par Value
Underlying amount
152,439
Exercise price
$16.85
Footnotes
F2, F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation.

Footnote F2

Reflects the grant of stock options to purchase common shares under the Plan.

Footnote F3

The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement.

Footnote F4

The stock options will expire on the tenth anniversary of the grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .